Literature DB >> 24716656

Pain quality of life as measured by utilities.

Sarah Wetherington1, Laura Delong, Seema Kini, Emir Veledar, Michael K Schaufele, Anne M McKenzie-Brown, Suephy C Chen.   

Abstract

OBJECTIVE: Utilities are values of health-related quality of life (HRQoL) based on patient preference for a health status. The purpose of this study was to compare indirect measures to a directly elicited utility.
DESIGN: Cross-sectional study. SETTING AND PATIENTS: Emory Spine Center and the Emory Center for Chronic Pain at Crawford Long Hospital. Patients at least 18 years of age with chronic pain, defined as pain that persists beyond the normal time of healing, usually beyond 6 months. MEASURES: Chronic pain subjects completed a paper-based, self-administered time trade-off (TTO) survey, EQ-5D survey, and a face-to-face (FTF) TTO interview. Current pain severity was graded using the Numeric Rating Scale-11, subsequently stratified into no (0), mild (1-3), moderate (4-6), and severe (7-10) pain.
RESULTS: Paired t test comparing FTF TTO and proxy utility measures stratified by severity revealed FTF TTO utility values significantly higher than EQ-5D utility values for all pain severities (overall mean difference 0.18, standard deviation [SD] 0.30, P < 0.001; Pearson's correlation 0.34, P < 0.0001); FTF TTO utility values were lower than paper TTO utility values, reaching statistical significance for mild and moderate pain (overall mean difference 0.09, SD 0.29, P = 0.0006; Pearson's correlation 0.38, P < 0.0001).
CONCLUSIONS: This study demonstrates that the EQ-5D overestimates, whereas the paper version of TTO underestimates, the impact of pain on HRQoL compared with the directly elicited FTF TTO utility. Our findings provide preliminary evidence that utilities vary by method, and directly elicited utility values differ from indirectly elicited measures. Wiley Periodicals, Inc.

Entities:  

Keywords:  EQ-5D; EuroQoL; Measurement; Pain; Quality of Life; Utility

Mesh:

Year:  2014        PMID: 24716656     DOI: 10.1111/pme.12405

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  4 in total

1.  Budget Impact and Cost-Effectiveness of Intravenous Meloxicam to Treat Moderate-Severe Postoperative Pain.

Authors:  John A Carter; Libby K Black; Kathleen L Deering; Jonathan S Jahr
Journal:  Adv Ther       Date:  2022-06-09       Impact factor: 4.070

2.  Cost-effectiveness of a chronic pain intervention for people living with HIV (PLWH).

Authors:  Jessica S Merlin; Andrew O Westfall; Mallory O Johnson; Robert D Kerns; Matthew J Bair; Stefan Kertesz; Janet M Turan; Olivio J Clay; Joanna L Starrels; Meredith Kilgore
Journal:  J Med Econ       Date:  2017-09-18       Impact factor: 2.448

3.  Pharmacoepidemiologic analyses of opioid use among OEF/OIF/OND veterans.

Authors:  Teresa J Hudson; Jacob T Painter; Bradley C Martin; Mark A Austen; James S Williams; John C Fortney; Mark D Sullivan; Mark J Edlund
Journal:  Pain       Date:  2017-06       Impact factor: 6.961

4.  Comparing Utility Scores in Common Spinal Radiculopathies: Results of a Prospective Valuation Study.

Authors:  Nikhil R Nayak; James H Stephen; Kalil G Abdullah; Sherman C Stein; Neil R Malhotra
Journal:  Global Spine J       Date:  2015-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.